Leveraging AI and genomics, Nuritas has built the leading discovery and development platform for bioactive, cell signalling peptides, – naturally occurring proteins – empowering consumers to live healthier lives by making the products they consume everyday safer, healthier and more sustainable.
Through its AI Magnifier technology platform, Nuritas has explored billions of peptides and identified a library of more than eight million with known functionalities to create powerful, precise ingredients aimed at supercharging our natural processes.
Its portfolio of 56 clinically-proven patented peptides covers health benefits ranging from strength, energy, and recovery, collagen production, sleep improvement and enhancing metabolism.
They are formulated inside various FMCG products globally, allowing its customers to add transformative value and differentiation to their brands.
For more information on Grosvenor Food & AgTech's investment in Nuritas please contact:
Stephan Dolezalek
Managing Partner, Grosvenor Food & AgTech
+1 628 244 0009
stephan.dolezalek@grosvenor.com